Novo Nordisk A/S (NONOF)
OTC: NONOF
· Real-Time Price · USD
54.58
3.38 (6.60%)
At close: Aug 18, 2025, 3:57 PM
54.58
0.00%
After-hours: Aug 18, 2025, 03:39 PM EDT
Novo Nordisk A/S Revenue
Novo Nordisk A/S reported an annual revenue of $290.4B, reflecting a 25.03% growth. For the quarter ending March 31, 2025, Novo Nordisk A/S generated $78.09B in revenue.
Revenue (ttm)
290.4B
Revenue Growth
25.03%
Price / Sales Ratio
9.49
Revenue / Employee
3.75M
Employees
77,406
Market Cap
242.53B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 290.4B | +25.03% |
| Dec 31, 2023 | 232.26B | +31.26% |
| Dec 31, 2022 | 176.95B | +25.68% |
| Dec 31, 2021 | 140.8B | +10.91% |
| Dec 31, 2020 | 126.95B | +4.04% |
| Dec 31, 2019 | 122.02B | +9.11% |
| Dec 31, 2018 | 111.83B | +0.12% |
| Dec 31, 2017 | 111.7B | -0.08% |
| Dec 31, 2016 | 111.78B | +3.57% |
| Dec 31, 2015 | 107.93B | +21.53% |
| Dec 31, 2014 | 88.81B | +6.26% |
| Dec 31, 2013 | 83.57B | +7.11% |
| Dec 31, 2012 | 78.03B | +17.60% |
| Dec 31, 2011 | 66.35B | +9.16% |
| Dec 31, 2010 | 60.78B | +18.99% |
| Dec 31, 2009 | 51.08B | +11.85% |
| Dec 31, 2008 | 45.67B | +9.02% |
| Dec 31, 2007 | 41.89B | +8.09% |
| Dec 31, 2006 | 38.75B | +14.94% |
| Dec 31, 2005 | 33.71B | +15.33% |
| Dec 31, 2004 | 29.23B | +9.85% |
| Dec 31, 2003 | 26.61B | +5.80% |
| Dec 31, 2002 | 25.15B | +6.06% |
| Dec 31, 2001 | 23.72B | +13.94% |
| Dec 31, 2000 | 20.82B | -0.62% |
| Dec 31, 1999 | 20.94B | +16.94% |
| Dec 31, 1998 | 17.91B | +5.45% |
| Dec 31, 1997 | 16.98B | +13.96% |
| Dec 31, 1996 | 14.9B | +8.68% |
| Dec 31, 1995 | 13.71B | +1.44% |
| Dec 31, 1994 | 13.52B | +2.83% |
| Dec 31, 1993 | 13.15B | +23.19% |
| Dec 31, 1992 | 10.67B | +8.56% |
| Dec 31, 1991 | 9.83B | +17.97% |
| Dec 31, 1990 | 8.33B | +9.36% |
| Dec 31, 1989 | 7.62B | +35.34% |
| Dec 31, 1988 | 5.63B | +11.97% |
| Dec 31, 1987 | 5.03B | +20.07% |
| Dec 31, 1986 | 4.19B | +0.70% |
| Dec 31, 1985 | 4.16B | n/a |